Sphingomyelinase has an insulin-like effect on glucose transporter translocation in adipocytes

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  David, T S ^b   Ortiz, P A ^b   Smith, T R ^b   Turinsky, J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

GLUT 1; GLUT 4; Insulin receptor substrate 1; Insulin receptor subunit; Tumor necrosis factor

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; GLUTAMYLGLYCINE; INSULIN RECEPTOR; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CHAIN; ENZYME ACTIVATION; ENZYME ACTIVITY; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE TRANSLOCATION; MALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0031859714     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.5.r1446     Document Type: Article

References (36)

1. Avruch, J., and D. F. Hoelzl-Wallach. Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim. Biophys. Acta 233: 334-347, 1971.
2. Barnholz, Y., A. Roitman, and S. Gatt. Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain. J. Biol. Chem. 241: 3731-3737, 1966.
3. Coroneos, E., M. Martinez, S. McKenna, and M. Kester. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J. Biol. Chem. 270: 23305-23309, 1995.
4. Dobrowsky, R. T., and Y. A. Hannun. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 267: 5048-5051, 1992.
5. Goldkorn, T., K. A. Dressler, J. Muindi, N. S. Radin, J. Mendelsohn, D. Menaldino, D. Liotta, and R. N. Kolesnick. Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. Evidence that ceramide may mediate sphingosine action. J. Biol. Chem. 266: 16092-16097, 1991.
6. Guo, D., and D. B. Donner. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J. Biol. Chem. 271: 615-618, 1996.
7. Hannun, Y. A., C. R. Loomis, A. H. Merrill, Jr., and R. M. Bell. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261: 12604-12609, 1986.
8. Henriksen, E. J., K. J. Rodnick, and J. O. Holloszy. Activation of glucose transport in skeletal muscle by phospholipase C and phorbol ester. Evaluation of the regulatory roles of protein kinase C and calcium. J. Biol. Chem. 264: 21536-21543, 1989. [Corrigenda. J. Biol. Chem. 265: April 1990, p. 5917.]
9. Hotamisligil, G. S., A. Budavari, D. Murray, and B. M. Spiegelman. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94: 1543-1549, 1994.
10. Hotamisligil, G. S., D. L. Murray, L. N. Choy, and B. M. Spiegelman. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91: 4854-4858, 1994.
11. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
12. Jayadev, S., B. Liu, A. E. Bielawska, J. Y. Lee, F. Nazaire, M. Y. Pushkareva, L. M. Obeid, and Y. A. Hannun. Role for ceramide in cell cycle arrest. J. Biol. Chem. 270: 2047-2052, 1995.
13. Kanety, H., R. Feinstein, M. Z. Papa, R. Hemi, and A. Karasik. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J. Biol. Chem. 270: 23780-23784, 1995.
14. Kanety, H., R. Hemi, M. Z. Papa, and A. Karasik. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J. Biol. Chem. 271: 9895-9897, 1996.
15. Kim, M. Y., C. Linardic, L. Obeid, and Y. Hannun. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J. Biol. Chem. 266: 484-489, 1991.
16. Kolesnick, R. N. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J. Biol. Chem. 262: 16759-16762, 1987.
17. Kolesnick, R. N. Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells. J. Biol. Chem. 264: 7617-7623, 1989.
18. Lang, C. H., C. Dobrescu, and G. J. Bagby. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43-52, 1992.
19. Mathias, S., A. Younes, C. C. Kan, I. Orlow, C. Joseph, and R. N. Kolesnick. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259: 519-522, 1993.
20. 3 in HL-60 cells. Role in cell differentiation. J. Biol. Chem. 264: 19076-19080, 1989.
21. 3-induced HL-60 cell differentiation. J. Biol. Chem. 269: 4070-4077, 1994.
22. Olivera, A., N. E. Buckley, and S. Spiegel. Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J. Biol. Chem. 267: 26121-26127, 1992.
23. Raines, M. A., R. N. Kolesnick, and D. W. Golde. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268: 14572-14575, 1993.
24. Rao, B. G., and M. W. Spence. Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J. Lipid Res. 17: 506-515, 1976.
25. Rosenwald, A. G., and R. E. Pagano. Inhibition of glycoprotein traffic through the secretory pathway by ceramide. J. Biol. Chem. 268: 4577-4579, 1993.
26. Schutze, S., T. Machleidt, and M. Kronke. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J. Leukoc. Biol. 56: 533-541, 1994.
27. Schutze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71: 765-776, 1992.
28. Smith, T. R., J. S. Elmendorf, T. S. David, and J. Turinsky. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E1071-E1079, 1997.
29. Sowell, M. O., K. P. Boggs, K.A. Robinson, S. L. Dutton, and M. G. Buse. Effects of insulin and phospholipase C in control and denervated rat skeletal muscle. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E247-E256, 1991.
30. Turinsky, J., B. P. Bayly, and D. M. O'Sullivan. 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin. J. Biol. Chem. 265: 7933-7938, 1990.
31. Turinsky, J., G. W. Nagel, J. S. Elmendorf, A. Damrau-Abney, and T. R. Smith. Sphingomyelinase stimulates 2-deoxyglucose uptake by skeletal muscle. Biochem. J. 313: 215-222, 1996.
32. Turinsky, J., D. M. O'Sullivan, and B. P. Bayly. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J. Biol. Chem. 265: 16880-16885, 1990.
33. Weber, T. M., H.-G. Joost, I. A. Simpson, and S. W. Cushman. Methods for assessment of glucose transport activity and the number of glucose transporters in isolated rat adipose cells and membrane fractions. In: Insulin Receptors: Clinical Assessment, Biological Responses, and Comparison to the IGF-1 Receptor, edited by C. R. Kahn and L. C. Harrison. New York: Liss, 1988, pt. B, p. 171-187.
34. Westwick, J. K., A. E. Bielawska, G. Dbaibo, Y. A. Hannun, and D. A. Brenner. Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270: 22689-22692, 1995.
35. Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, and M. Kronke. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015, 1994.
36. Yanaga, F., and S. P. Watson. Tumor necrosis factor alpha stimulates sphingomyelinase through the 55 kDa receptor in HL-60 cells. FEBS Lett. 314: 297-300, 1992.